Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Enterprise East Introduces New £1.5m Early-Stage Medtech Fund

Executive Summary

UK NHS innovation hub Health Enterprise East has launched a new proof-of-concept financial awards scheme to support early stage-medtech innovation developed within the National Health Service. The organization plans to launch a larger second investment fund in early 2017 to support later-stage technology.

You may also be interested in...



Early-Stage UK NHS Innovations Get Sterling Boost From Medtech Accelerator

A new UK-based innovations award has selected its first batch of winners; the three projects that sprung from the National Health Service will share the £200,000 prize money to help progress their early-stage technologies. The Medtech Accelerator was launched at the end of 2016 as a joint venture between the NHS and regional business partners to provide funding for pioneering medical technologies developed by NHS staff.

Allergan All Ears To Expand Minimally Invasive earFold Device

Allergan is ramping up commercialization of its earFold implantable device for reshaping prominent ears, which it acquired nearly two years ago. The device has been launched in private clinics across the UK and Europe as a minimally invasive alternative to standard otoplasty surgery.

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104190

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel